MetroGel
Rosacea
ApprovedCommercial
Key Facts
About Galderma Group
Galderma Group is a premier dermatology-focused pharmaceutical company headquartered in Switzerland, serving healthcare professionals and patients worldwide with medical dermatology treatments, aesthetic solutions, and consumer skincare products. The company has established itself as a leader in dermatological innovation through its extensive research and development programs and comprehensive product portfolio. Following its successful IPO in 2024, Galderma continues to expand its global presence and advance its pipeline of dermatology treatments.
View full company profileTherapeutic Areas
Other Rosacea Drugs
| Drug | Company | Phase |
|---|---|---|
| Emrosi™ (Minocycline Hydrochloride ER Capsules, 40 mg) | Fortress Biotech | Approved/Commercial |
| Zilxi | Vyne Therapeutics | Approved |